Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver ...
As the tax year draws to a close, tax-efficient investments once again move sharply into focus for advisers supporting ...
With investors rushing to secure Venture Capital Trust (VCT) allocations ahead of the expected reduction in the 30% income tax relief, ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する